Displaying 91 - 108 of 161
How is radiation regulated in Australia? It’s a common question, and unfortunately the answer isn’t as straightforward as it could be.
In June 2018, ARPANSA issued a direction to its licence holder, the Australian Nuclear Science and Technology Organisation (ANSTO), to initiate an independent review of its approach to occupational radiation safety at its nuclear medicine facility operated by ANSTO Health, now known as Health Products.
Dr Ken Karipidis, ARPANSA’s Assistant Director of Assessment and Advice, recently attended a workshop hosted by the German Federal Office for Radiation Protection (BfS) to explore effects of electric, magnetic and electromagnetic fields on animals and plants.
The Australian Radiation Protection and Nuclear Safety (ARPANS) Regulations provide a framework for ensuring Commonwealth Government bodies that use or produce radiation conduct their work in a safe and responsible manner.
ARPANSA has provided a submission to the 2019 parliamentary inquiry into the benefits and challenges of 5G – the fifth generation of the mobile telecommunications network.
The submission provides information about the safety of radio waves from 5G.
ARPANSA is pleased to host, in conjunction with the International Commission of Radiological Protection (ICRP) and the Australasian Radiation Protection Society (ARPS), the 5th International Symposium on the System of Radiological Protection on 17-21 November 2019 in Adelaide, South Australia.
ARPANSA is currently seeking nominations for members of the Radiation Health and Safety Advisory Council. The Minister-appointed Council advise the CEO on emerging issues and matters of major public concern relating to radiation protection and nuclear safety.
The Annual Report of the CEO of ARPANSA 2018-19 was tabled in parliament on Tuesday 15 October 2019 and is now available on the new transparency portal.
In the first study of its kind in Australia, ARPANSA produced a report on radiation in foods that make up a typical Australian diet. The results showed levels are very low and do not present any health concerns.
Earlier this month ARPANSA and Cancer Council Victoria (CCV) met to formalise our partnership to promote sun safety and support skin cancer prevention.
Part of ARPANSA’s role is the regulation of all Commonwealth entities that use radiation. Regulation ensures compliance with the Australian Radiation Protection and Nuclear Safety Act 1998 and associated Regulations (2018) and is supported by a series of regulatory guides.
In December 2018, the British Medical Journal Open published a scientific study led by ARPANSA investigating the relationship between brain cancer and mobile phone use.
Since the publication of the original study, the authors have conducted further analysis of additional age groups.
We’re pleased to announce that the newest location in our ultraviolet (UV) radiation monitoring network is now online. Emerald is the fourth location in Queensland to join our network of real-time UV data.
ARPANSA collates and publishes an annual report on radiation incidents in Australia. This report is produced with input from various radiation regulators around the country, based on incidents submitted to them and any subsequent investigations they carry out.
In Australia, skin cancer accounts for around 80% of all newly diagnosed cancers each year and UV radiation from the sun is one of the leading causes of skin cancer. With high UV radiation year-round in many parts of Australia, people who regularly work outside face a higher risk of developing cancer from sun exposure.
Dr Gillian Hirth, deputy CEO and Head of ARPANSA's Radiation Health Services Branch, has been elected as Chair of the United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR) for the 66th and 67th sessions
Production of nuclear medicine at ANSTO’s Nuclear Medicine facility was halted on 21 June following an accident in which the hands of three workers were exposed to radiation.
On Friday 21 June 2019, ARPANSA was notified of a radiation contamination event at the Australian Nuclear Science and Technology Organisation (ANSTO) Nuclear Medicine (ANM) production facility in Lucas Heights, New South Wales.
